- Home
- CCEL vs ECOR Comparison
CCEL vs ECOR Comparison
Compare CCEL & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- ECOR
- Stock Information
- Founded
- CCEL 1989
- ECOR 2005
- Country
- CCEL United States
- ECOR United States
- Employees
- CCEL N/A
- ECOR N/A
- Industry
- CCEL Managed Health Care
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CCEL Health Care
- ECOR Health Care
- Exchange
- CCEL Nasdaq
- ECOR Nasdaq
- Market Cap
- CCEL 35.8M
- ECOR 39.6M
- IPO Year
- CCEL 1997
- ECOR 2018
- Fundamental
- Price
- CCEL $4.30
- ECOR $4.90
- Analyst Decision
- CCEL Hold
- ECOR Strong Buy
- Analyst Count
- CCEL 1
- ECOR 2
- Target Price
- CCEL N/A
- ECOR $25.50
- AVG Volume (30 Days)
- CCEL 4.3K
- ECOR 79.4K
- Earning Date
- CCEL 10-15-2025
- ECOR 11-05-2025
- Dividend Yield
- CCEL 9.30%
- ECOR N/A
- EPS Growth
- CCEL N/A
- ECOR N/A
- EPS
- CCEL N/A
- ECOR N/A
- Revenue
- CCEL $31,747,500.00
- ECOR $29,835,000.00
- Revenue This Year
- CCEL $0.30
- ECOR $24.55
- Revenue Next Year
- CCEL N/A
- ECOR $41.13
- P/E Ratio
- CCEL N/A
- ECOR N/A
- Revenue Growth
- CCEL N/A
- ECOR 27.90
- 52 Week Low
- CCEL $4.00
- ECOR $4.16
- 52 Week High
- CCEL $9.10
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- CCEL 51.29
- ECOR 47.21
- Support Level
- CCEL $4.04
- ECOR $4.77
- Resistance Level
- CCEL $4.45
- ECOR $5.14
- Average True Range (ATR)
- CCEL 0.13
- ECOR 0.36
- MACD
- CCEL 0.03
- ECOR -0.07
- Stochastic Oscillator
- CCEL 67.26
- ECOR 23.39
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.